CLINICAL_TRIALS
trial_result
· 2021-03-02
Clinical Trial Update: Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001) [Phase 1]
Summary
Phase 1 extension study of OCV-501 in acute myeloid leukemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2021-03-02